Summary

Global Genotyping Market was valued at USD 16.25 billion in 2024 and is expected to reach USD 26.87 billion by 2030 with a CAGR of 8.74% during the forecast period. The global genotyping market is a dynamic and rapidly growing sector within the field of biotechnology and life sciences. Genotyping is the process of determining an individual's genetic makeup, including variations in their DNA sequence. This information is crucial for a wide range of applications, from personalized medicine and disease research to agriculture and ancestry testing.
The genotyping market is expected to experience growth driven by increased government funding, particularly for genomic research from governmental bodies, as well as contributions from pharmaceutical and biotechnology companies, aimed at expediting research. A noteworthy example of this is the National Institutes of Health (NIH) granting USD 28.6 million in September 2018 to the "All of Us Research Program" for establishing three genome centers across the United States dedicated to precision medicine research.
The global rise in chronic diseases, including cancer and genetic disorders, is set to fuel the demand for genotypic-based diagnostic testing. To illustrate, the World Health Organization (WHO) reported 19.1 million new cancer cases diagnosed worldwide in 2020. Moreover, cancer-causing viruses like Human Papilloma Virus (HPV) and Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) are responsible for approximately 20% of cancer-related deaths on a global scale. The number of cancer cases is projected to increase by roughly 70% over the next two decades, driven by population growth and aging. Therefore, the increasing prevalence of cancer is expected to be a significant driving force for this market.
Key Market Drivers
Advancements in Genotyping Technologies
Genotyping, the process of analyzing an individual's genetic makeup, is undergoing a revolution thanks to advancements in genotyping technologies. These innovations have not only enhanced the efficiency and accuracy of genotyping but also expanded its applications across various sectors, including healthcare, research, agriculture, and personalized medicine. One of the most significant factors propelling the genotyping market forward is the advent of high-throughput genotyping platforms. These platforms can analyze thousands or even millions of genetic markers in a single experiment, significantly increasing the speed and cost-effectiveness of genotyping. Researchers and clinicians can process larger datasets quickly, making genotyping accessible for a wide range of applications.
Next-generation sequencing, or NGS, is a game-changer in genotyping. It allows for the simultaneous sequencing of a person's entire genome, making it possible to identify even the rarest genetic variations. NGS is not only faster and more affordable than traditional Sanger sequencing, but it also generates vast amounts of data, enabling comprehensive genomic analysis. This technology has become essential in research, clinical diagnostics, and personalized medicine. Advancements in genotyping technologies have significantly improved the accuracy and resolution of genotyping results. Single nucleotide polymorphism (SNP) genotyping, for example, has become highly accurate, making it an invaluable tool in identifying genetic markers associated with diseases, drug responses, and other traits. This precision has bolstered the credibility of genotyping in both research and clinical applications.
Key Market Challenges
Data Management and Interpretation
One of the primary challenges in the genotyping market is the management and interpretation of the massive amounts of genetic data generated. Genotyping technologies, especially high-throughput platforms and next-generation sequencing, produce enormous datasets. The efficient analysis and interpretation of this data requires robust bioinformatics tools and skilled personnel, making data management a significant hurdle.
Key Market Trends
Integration of Multi-Omics Approaches
Genotyping is increasingly being integrated with other omics technologies such as proteomics and metabolomics. This holistic approach allows researchers to gain a more comprehensive understanding of biological systems. By analyzing genetic, protein, and metabolic data together, researchers can uncover intricate relationships and potential biomarkers for various diseases and conditions.
Key Market Players
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• QIAGEN N.V.
• F Hoffmann-La Roche AG
• Danaher Corporation
• Agilent Technologies, Inc.
• Eurofins Scientific Inc.
• GE HealthCare
• Bio-Rad Laboratories Inc.
• Standard BioTools™
Report Scope:
In this report, the Global Genotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Genotyping Market, By Product:
o Instruments
o Reagents & Kits
o Software and Services
• Genotyping Market, By Technology:
o PCR
o Capillary Electrophoresis
o Microarrays
o Sequencing
o Mass Spectrometry
o Others
• Genotyping Market, By Application:
o Pharmacogenomics
o Diagnostics and Personalized Medicine
o Agricultural Biotechnology
o Animal Genetics
o Others
• Genotyping Market, By End Use:
o Pharmaceutical and Biopharmaceutical Companies
o Diagnostics and Research Laboratories
o Academic Institutes
o Others
• Genotyping Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Genotyping Market.
Available Customizations:
Global Genotyping market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Genotyping Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
5.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End Use
5.3.5. By Region
6. North America Genotyping Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
6.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
6.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
6.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Genotyping Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End Use
6.3.2. Canada Genotyping Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End Use
6.3.3. Mexico Genotyping Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End Use
7. Europe Genotyping Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
7.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
7.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
7.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Genotyping Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End Use
7.3.2. United Kingdom Genotyping Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End Use
7.3.3. France Genotyping Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End Use
7.3.4. Italy Genotyping Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End Use
7.3.5. Spain Genotyping Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End Use
8. Asia-Pacific Genotyping Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
8.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
8.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
8.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Genotyping Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End Use
8.3.2. Japan Genotyping Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End Use
8.3.3. India Genotyping Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End Use
8.3.4. Australia Genotyping Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End Use
8.3.5. South Korea Genotyping Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End Use
9. South America Genotyping Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
9.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
9.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
9.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Genotyping Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End Use
9.3.2. Argentina Genotyping Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End Use
9.3.3. Colombia Genotyping Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End Use
10. Middle East and Africa Genotyping Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
10.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
10.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
10.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Genotyping Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Genotyping Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End Use
10.3.3. UAE Genotyping Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End Use
10.3.4. Kuwait Genotyping Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Technology
10.3.4.2.3. By Application
10.3.4.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Thermo Fisher Scientific Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Illumina Inc.
14.3. QIAGEN N.V.
14.4. F Hoffmann-La Roche AG
14.5. Danaher Corporation
14.6. Agilent Technologies, Inc.
14.7. Eurofins Scientific Inc.
14.8. GE HealthCare
14.9. Bio-Rad Laboratories Inc.
14.10. Standard BioTools™
15. Strategic Recommendations
16. About Us & Disclaimer